[go: up one dir, main page]

WO1999006551B1 - Est 5' pour proteines secretees identifiees dans le tissu cerebral - Google Patents

Est 5' pour proteines secretees identifiees dans le tissu cerebral

Info

Publication number
WO1999006551B1
WO1999006551B1 PCT/IB1998/001235 IB9801235W WO9906551B1 WO 1999006551 B1 WO1999006551 B1 WO 1999006551B1 IB 9801235 W IB9801235 W IB 9801235W WO 9906551 B1 WO9906551 B1 WO 9906551B1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
nos
sequences
cdna
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB1998/001235
Other languages
English (en)
Other versions
WO1999006551A3 (fr
WO1999006551A2 (fr
Inventor
Milne Edwards Jean-Bapti Dumas
Aymeric Duclert
Bruno Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Priority to EP98936593A priority Critical patent/EP1000149B1/fr
Priority to JP2000505292A priority patent/JP2001512014A/ja
Priority to DK98936593T priority patent/DK1000149T3/da
Priority to DE69837761T priority patent/DE69837761T2/de
Priority to CA002296809A priority patent/CA2296809A1/fr
Priority to AU85554/98A priority patent/AU8555498A/en
Publication of WO1999006551A2 publication Critical patent/WO1999006551A2/fr
Publication of WO1999006551A3 publication Critical patent/WO1999006551A3/fr
Publication of WO1999006551B1 publication Critical patent/WO1999006551B1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des séquences EST 5' (marqueurs séquentiels exprimés) dérivées d'ARNm codant des protéines sécrétées. Les EST 5' peuvent être utilisés pour la production d'ADNc et d'ADN génomiques correspondant aux EST 5'. Les EST 5' peuvent également être utilisés dans le diagnostic, la médecine légale, la thérapie génique et les procédures de cartographie des gènes. Des séquences de régulation d'amont peuvent également être produites au moyen des EST 5'. Les EST 5' peuvent également être utilisés pour la mise au point de vecteurs d'expression et de vecteurs de sécrétion.
PCT/IB1998/001235 1997-08-01 1998-07-31 Est 5' pour proteines secretees identifiees dans le tissu cerebral Ceased WO1999006551A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP98936593A EP1000149B1 (fr) 1997-08-01 1998-07-31 Est 5' pour proteines secretees identifiees dans le tissu cerebral
JP2000505292A JP2001512014A (ja) 1997-08-01 1998-07-31 脳組織から同定された分泌タンパク質の５’ｅｓｔ
DK98936593T DK1000149T3 (da) 1997-08-01 1998-07-31 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv
DE69837761T DE69837761T2 (de) 1997-08-01 1998-07-31 5' ests für sekretierte proteine aus gehirngeweben
CA002296809A CA2296809A1 (fr) 1997-08-01 1998-07-31 Est 5' pour proteines secretees identifiees dans le tissu cerebral
AU85554/98A AU8555498A (en) 1997-08-01 1998-07-31 5' ests for secreted proteins identified from brain tissues

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90513397A 1997-08-01 1997-08-01
US08/905,133 1997-08-01

Publications (3)

Publication Number Publication Date
WO1999006551A2 WO1999006551A2 (fr) 1999-02-11
WO1999006551A3 WO1999006551A3 (fr) 1999-04-29
WO1999006551B1 true WO1999006551B1 (fr) 1999-06-03

Family

ID=25420334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1998/001235 Ceased WO1999006551A2 (fr) 1997-08-01 1998-07-31 Est 5' pour proteines secretees identifiees dans le tissu cerebral

Country Status (10)

Country Link
EP (1) EP1000149B1 (fr)
JP (1) JP2001512014A (fr)
AT (1) ATE361933T1 (fr)
AU (1) AU8555498A (fr)
CA (1) CA2296809A1 (fr)
DE (1) DE69837761T2 (fr)
DK (1) DK1000149T3 (fr)
ES (1) ES2287979T3 (fr)
PT (1) PT1000149E (fr)
WO (1) WO1999006551A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435793B2 (en) * 1998-05-15 2008-10-14 Genentech, Inc. Peptides that induce chondrocyte redifferentiation
AU2006201603B2 (en) * 1997-12-17 2007-05-24 Serono Genetics Institute S.A. Extended cDNAs for secreted proteins
DE19818620A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Normal
AU3965299A (en) * 1998-04-24 1999-11-16 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
US7125959B2 (en) 1998-05-15 2006-10-24 Genentech, Inc. PRO4405 polypeptides
AU777909B2 (en) * 1999-01-19 2004-11-04 Lexicon Genetics Incorporated Mammalian cortexin-like proteins and polynucleotides encoding the same
AU772103B2 (en) 1999-02-19 2004-04-08 Zymogenetics Inc. Inhibitors for use in hemostasis and immune function
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
AU2399300A (en) * 1999-03-08 2000-09-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
DE60045681D1 (de) 1999-03-11 2011-04-14 Merck Serono Sa Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
KR100504305B1 (ko) * 1999-03-23 2005-07-28 제넨테크, 인크. 분비 및 막횡단 폴리펩티드 및 이를 코딩하는 핵산
IL145971A0 (en) * 1999-04-20 2002-07-25 Zymogenetics Inc Adipocyte complement related protein homolog zacrp3
US6521233B1 (en) 1999-04-20 2003-02-18 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp3
EP2385124B1 (fr) * 1999-05-14 2013-09-11 Arbor Vita Corporation Peptides ou analogues de peptides pour moduler l'interaction entre und protéine PDZ et une protéine PL
AUPQ262599A0 (en) * 1999-09-02 1999-09-23 University Of Queensland, The Gene expression
CA2494705A1 (fr) * 1999-12-01 2001-06-07 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
US6984519B2 (en) * 2000-03-01 2006-01-10 Genetech, Inc. Nucleic acids encoding peptides that induce chondrocyte redifferentiation
EP1294762A2 (fr) * 2000-06-26 2003-03-26 Millennium Pharmaceuticals, Inc. 48000 et 52920, nouveaux canaux calciques humains et leurs utilisations
CA2429959A1 (fr) 2000-12-07 2002-06-13 Zymogenetics, Inc. Proteine associee au complement adipocyte zacrp3x2
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP1573024A4 (fr) 2001-04-10 2007-08-29 Agensys Inc Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
US8007797B2 (en) 2006-09-28 2011-08-30 Merck Serono S.A. Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use
EP2130836B1 (fr) * 2008-06-03 2013-02-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Supports et procédés de production de doigts de zinc et ses concatémères
IL204652A0 (en) 2010-03-22 2010-11-30 Univ Ben Gurion A system for detecting usability problems of users while using their mobile devices
WO2025169718A1 (fr) * 2024-02-09 2025-08-14 富士レビオ株式会社 Polypeptide multimérisé, bandelette immunochromatographique, dispositif immunochromatographique, kit immunochromatographique et procédé de détection d'analyte

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) * 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
JP2001512014A (ja) 2001-08-21
DE69837761T2 (de) 2008-01-17
AU8555498A (en) 1999-02-22
EP1000149B1 (fr) 2007-05-09
WO1999006551A3 (fr) 1999-04-29
DK1000149T3 (da) 2007-09-10
WO1999006551A2 (fr) 1999-02-11
DE69837761D1 (de) 2007-06-21
ATE361933T1 (de) 2007-06-15
PT1000149E (pt) 2007-08-03
EP1000149A2 (fr) 2000-05-17
CA2296809A1 (fr) 1999-02-11
ES2287979T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
WO1999006552B1 (fr) Est 5' pour proteines secretees exprimees dans le cerveau
WO1999006548B1 (fr) Est 5' pour proteines secretees sans specificite tissulaire
WO1999006554B1 (fr) Est 5' pour proteines secretees exprimees dans des tissus musculaires et autres tissus mesodermiques
WO1999006550B1 (fr) Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
WO1999006551B1 (fr) Est 5' pour proteines secretees identifiees dans le tissu cerebral
WO1999006553B1 (fr) Est 5' pour proteines secretees exprimees dans divers tissus
CA2336227A1 (fr) Genes jouant un role dans la tolerance au stress de l'environnement
ESCANDE et al. Human mucin gene MUC5AC: organization of its 5′-region and central repetitive region
WO1999043819B1 (fr) Famille de genes pr-1 et de promoteurs
DE69839426D1 (de) Nukleotidsequenzen, die für sekretierte polypeptide aus mycobacterium kodieren, vektoren, die diese enthalten, und anwendungen zur diagnostik und verhütung von tuberkulose
Sümegi et al. A hierarchic arrangement of the repetitive sequences in the Balbiani ring 2 gene of Chironomus tentans
DE60115900D1 (de) Nukleotidsequenzen kodierend für das mdha gen aus corynebakterium glutamicum
Cooley et al. Multiple combinations of alternatively spliced exons in rat tropomyosin-α gene mRNA: evidence for 20 new isoforms in adult tissues and cultured cells
WO2000000607B1 (fr) Acide nucleique codant pour une proteine de liaison du retinoblastome (rbp-7) et marqueurs polymorphes associes a cet acide nucleique
Ajioka et al. The calmodulin-ubiquitin associated genes of Trypanosoma cruzi: their identification and transcription
US6063595A (en) Method of forming a macromolecular microgene polymer
CA2573022A1 (fr) Nouvelle sequence pour ameliorer l'expression d'acide nucleique
KR920000932A (ko) 효소 및 이를 암호화하는 dna
CA2362518A1 (fr) Promoteur thermo-inductible
Zhang et al. cDNA sequences of variant forms of human placenta diamine oxidase
CA2284688A1 (fr) Pullulanase du mais
AU2001273977A1 (en) Novel nucleotide sequences coding for the glbo gene
Epplen et al. Expression of (cac) n/(gtg) n simple repetitive sequences in mRNA of human lymphocytes
CA2318490C (fr) Gene nouveau regissant la forme des feuilles
WO2002022633A3 (fr) Sequences nucleotidiques codant pour le gene atr61

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: B1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2296809

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2296809

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1998936593

Country of ref document: EP

Ref document number: 85554/98

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998936593

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1998936593

Country of ref document: EP